Pancreatic Cancer Research

ResearcherUniversity of RochesterActive in the last 2 years

Mark G. Ettel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0632-6373; OpenAlex author ID A5073107044. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma: Clinicopathologic and immunohistochemical study. First author DOI 10.1016/j.humpath.2024.01.013↗
  2. Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions. Co-author DOI 10.1016/j.pathol.2019.02.005↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Irene Y. Chen · 1 shared paper, 2024 · strength 0.21
  2. Richard Francis Dunne · 1 shared paper, 2024 · strength 0.21
  3. Diana Agostini‐Vulaj · 1 shared paper, 2024 · strength 0.21
  4. Wenjia Wang · 1 shared paper, 2024 · strength 0.21
  5. Aram F. Hezel · 1 shared paper, 2024 · strength 0.21
  6. Jiaqi Shi · 1 shared paper, 2019 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.